Assisted Movement Neuro-rehabilitation: VA Multi-site Clinical Trial
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00223808 |
Recruitment Status :
Completed
First Posted : September 22, 2005
Results First Posted : February 17, 2014
Last Update Posted : February 17, 2014
|
Sponsor:
US Department of Veterans Affairs
Information provided by (Responsible Party):
VA Office of Research and Development ( US Department of Veterans Affairs )
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Double (Participant, Outcomes Assessor); Primary Purpose: Treatment |
Conditions |
Cerebrovascular Disorders Hemiplegia |
Interventions |
Other: Robot-Low Other: Robot-High Other: Control |
Enrollment | 71 |
Participant Flow
Recruitment Details | Enrollment: November 2002 - December 2004 Enrollment sites: Michael E. DeBakey VA Medical Center, Houston, TX; VA Greater Los Angeles Healthcare System, Los Angeles, CA; and VA Palo Alto Health Care System, Palo Alto, CA. Data analysis site: Central Texas Veterans Health Care System, Temple, TX. |
Pre-assignment Details | 4 subjects excluded from group assignment due to medical conditions that precluded moderate-workload exercise. |
Arm/Group Title | Robot-Low | Robot-High | Control |
---|---|---|---|
![]() |
Mechanically-assisted upper limb exercise using MIME : 1 hour/day of robot-assisted upper limb therapy in addition to usual physical and occupational therapy | Mechanically-assisted upper limb exercise using MIME (high-dose) : 2 hours/day of robot-assisted therapy in addition to usual physical and occupational therapy | Additional usual therapy : 1 hour/day of additional upper limb therapy that includes exposure to, but no manipulation by the robot |
Period Title: Overall Study | |||
Started | 22 | 22 | 23 |
Completed | 19 [1] | 17 [1] | 18 [1] |
Not Completed | 3 | 5 | 5 |
Reason Not Completed | |||
<5 hrs therapy before discharge | 3 | 5 | 5 |
[1]
Completed at least the immediate post-treatment testing with 5 or more hours of treatment.
|
Baseline Characteristics
Arm/Group Title | Robot-Low | Robot-High | Control | Total | |
---|---|---|---|---|---|
![]() |
Mechanically-assisted upper limb exercise using MIME : 1 hour/day of robot-assisted upper limb therapy in addition to usual physical and occupational therapy | Mechanically-assisted upper limb exercise using MIME (high-dose) : 2 hours/day of robot-assisted therapy in addition to usual physical and occupational therapy | Additional usual therapy : 1 hour/day of additional upper limb therapy that includes exposure to, but no manipulation by the robot | Total of all reporting groups | |
Overall Number of Baseline Participants | 22 | 22 | 23 | 67 | |
![]() |
[Not Specified]
|
||||
Age, Categorical
Measure Type: Count of Participants Unit of measure: Participants |
|||||
Number Analyzed | 22 participants | 22 participants | 23 participants | 67 participants | |
<=18 years |
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Between 18 and 65 years |
16 72.7%
|
19 86.4%
|
10 43.5%
|
45 67.2%
|
|
>=65 years |
6 27.3%
|
3 13.6%
|
13 56.5%
|
22 32.8%
|
|
Age, Continuous
Mean (Standard Deviation) Unit of measure: Years |
|||||
Number Analyzed | 22 participants | 22 participants | 23 participants | 67 participants | |
62.95 (8.34) | 59.04 (9.30) | 67.87 (12.56) | 63.36 (10.75) | ||
Sex: Female, Male
Measure Type: Count of Participants Unit of measure: Participants |
|||||
Number Analyzed | 22 participants | 22 participants | 23 participants | 67 participants | |
Female |
0 0.0%
|
1 4.5%
|
0 0.0%
|
1 1.5%
|
|
Male |
22 100.0%
|
21 95.5%
|
23 100.0%
|
66 98.5%
|
|
Region of Enrollment
Measure Type: Number Unit of measure: Participants |
|||||
United States | Number Analyzed | 22 participants | 22 participants | 23 participants | 67 participants |
22 | 22 | 23 | 67 |
Outcome Measures
Adverse Events
Limitations and Caveats
Limitations include the relatively small number of subjects in each group and the variation in severity level across subjects. Subjects at the Houston site were enrolled earlier after stroke than in the LA site and the Palo Alto site.
More Information
Results Point of Contact
Name/Title: | Charles Burgar, MD |
Organization: | CTVHCS |
Phone: | 254/743-0085 |
EMail: | charles.burgar1@va.gov |
Responsible Party: | VA Office of Research and Development ( US Department of Veterans Affairs ) |
ClinicalTrials.gov Identifier: | NCT00223808 |
Obsolete Identifiers: | NCT00038324 |
Other Study ID Numbers: |
B2695-I |
First Submitted: | September 14, 2005 |
First Posted: | September 22, 2005 |
Results First Submitted: | October 9, 2013 |
Results First Posted: | February 17, 2014 |
Last Update Posted: | February 17, 2014 |